CIDP diagnostic pitfalls and perception of treatment benefit
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received December 22, 2014
- Accepted in final form March 27, 2015
- First Published July 15, 2015.
Article Versions
- Previous version (July 15, 2015 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Jeffrey A. Allen, MD and
- Richard A. Lewis, MD
- Jeffrey A. Allen, MD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Axcelacare (2) CSL Behring
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Richard A. Lewis, MD
Novartis DSMB for trial of Gilenya in CIDP Steering Committee for CSL Behring Hizentra in CIDP trial
NONE
Walgreen's for Barrow's Neuromuscular Colloquium
Editorial Boards: Journal of Neurological Science Journal of Neuromuscular Disorders
NONE
Up to Date: Article on CIDP
NONE
Axelacare CSL Behring Noavartis
NONE
NONE
I do EMGs for 30% of my activities
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (J.A.A.), University of Minnesota, Minneapolis; the Department of Neurology (J.A.A.), Northwestern University, Chicago, IL; and the Department of Neurology (R.A.L.), Cedars-Sinai Medical Center, Los Angeles, CA.
- Correspondence to Dr. Allen: jallen1{at}nmff.org
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.